The initial success of Sildenafil undeniably revolutionized the drug landscape, but betting in companies strongly reliant on off-patent versions presents a challenging picture. While early returns were impressive, the cessation of patents check here and the emergence of cheaper alternatives have diminished market share. Thus, a thorough analysis of